by Frank Gray | Dec 30, 2022 | Featured
By Tré LaRosa NeuLine Health The origins of the FDA’s Patient-Focused Drug Development Program Around ten years ago, the Food and Drug Administration (FDA) acknowledged the unmet need — and urgency — of including patient perspective in drug and device development in a... 
by Frank Gray | Dec 30, 2022 | Featured
By Tré LaRosa NeuLine Health PROs and clinical trials While patient-reported outcomes are becoming increasingly standard in clinical trials, their impact still needs to be fully understood. Clinical trials, like peer-reviewed journals, face scrutiny and require... 
by Frank Gray | Dec 13, 2022 | Featured
By Tré LaRosa NeuLine Health Patient-Reported Outcomes: The Basics Patient-reported outcomes (PROs) are clinical trial measures that capture the patient’s own perspective on how they feel. While they are commonly used in clinical trials, they are also used in the... 
by Frank Gray | Nov 18, 2022 | Brain Health, Featured
By Tré LaRosa NeuLine Health Interest — social, financial, and academic — in artificial intelligence has exploded in the last decade: Since 2016, an ETF focused on artificial intelligence and robotics has jumped 148%. A basic PubMed search for “artificial... 
by Frank Gray | Nov 17, 2022 | Alzheimer's, Dementia, Featured
By Tré LaRosa NeuLine Health One devastating consequence of dementias is how they degrade a person’s sense of self. This aspect of dementia has a crater-sized impact on those with dementia, but the progressive cognitive decline also enacts compounded suffering on...
Recent Comments